Institut Gustave Roussy
VC Fund
Villejuif, France
Institut Gustave Roussy is a VC fund in Villejuif focused on Medical and Hospital. The Institut Gustave-Roussy is one of the world’s leading cancer-research institutes and the biggest health center dedicated to oncology.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Institut Gustave Roussy invests in
Stages Institut Gustave Roussy invests in
Countries Institut Gustave Roussy invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Angelo Paci
|
|||
Antoine Italiano
|
|||
Arnaud Bayle
|
|||
Eric Deutsch
|
|||
Thierry de Baère
|
Investment Focus
Industry
- Medical 1 (100%)
- Hospital 1 (100%)
- Therapeutics 1 (100%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Angelo Paci
Head of the Pharmacology and Drug Analysis Department
|
Head of the Pharmacology and Drug Analysis Department | Total investments: 0 | Find email | |
|
Antoine Italiano
Head of Precision Medicine
|
Head of Precision Medicine | Total investments: 0 | Find email | |
|
Arnaud Bayle
Assistant Clinical Manager (CCA) - DITEP (Drug Development Department)
|
Assistant Clinical Manager (CCA) - DITEP (Drug Development Department) | Total investments: 0 | Find email | |
|
Eric Deutsch
Chairman of Radiation Oncology
|
Chairman of Radiation Oncology | Total investments: 0 | Find email | |
|
Thierry de Baère
Head of the Interventional Radiology Unit
|
Head of the Interventional Radiology Unit | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
TheraSonic
|
TheraSonic aims to revolutionize the treatment of neurological diseases, particularly brain cancers. | $1.1M / Seed / May 14, 2024 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Institut Gustave Roussy invest in?
Institut Gustave Roussy invests primarily in Medical, Hospital and Therapeutics startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Institut Gustave Roussy?
Public channels for Institut Gustave Roussy include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Institut Gustave Roussy?
The team at Institut Gustave Roussy includes Angelo Paci (Head of the Pharmacology and Drug Analysis Department), Antoine Italiano (Head of Precision Medicine) and Arnaud Bayle (Assistant Clinical Manager (CCA) - DITEP (Drug Development Department)). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
